Agilent opens new Frederick facility
FREDERICK — Agilent Technologies Inc. (NYSE: A), a pharmaceutical ingredient manufacturer, has opened a new manufacturing facility in Frederick.
The new $185-million, 135,000-square-foot operation will make oligonucleotide active pharmaceutical ingredients. Those products, known as “oligos,” are short DNA and RNA molecules that customers use to produce nucleic acid-based therapeutics, according to a company news release.
The Frederick site complements Agilent’s existing Boulder manufacturing site.
“We’re committed to Frederick and the state of Colorado,” Brian Carothers, vice president of Agilent’s Nucleic Acid Solutions Division, said in a…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
Outside Interactive Inc. has purchased the MapMyFitness application platform from Under Armour Inc.
-
Voters in the southeastern Weld County town of Hudson were opposing Ballot Issue 2F, a…
-
TiFin Group , a Boulder-based financial technology umbrella company, has offloaded its ownership stake in…
-
Electrasteel Inc., a developer of a more-sustainable iron and steel production process that does business…
